Wednesday, November 5

Oncolytics

Human Clinical Studies by Oncolytics Biotech Inc, have shown that a naturally occuring Reovirus can be used to successfully treat cancer, with no adverse events related to the virus and no dose-limiting toxicites were detected. Impressive before/after shots from one patient are included halfway down the page.

The FAQ has some interesting facts about the virus.

No comments: